Valuation : Dil Ltd

Market Cap 14.34B 150M 150M 129M 121M 111M 208M 209M 1.44B 561M 7.24B 563M 551M 24B P/E 2025
10.4x
P/E 2026 13x
Enterprise Value 15.15B 158M 158M 137M 128M 117M 220M 221M 1.52B 593M 7.65B 595M 582M 25.35B EV / Sales 2025
1.81x
EV / Sales 2026 1.94x
Free-Float
28.52%
Yield 2025
0.91%
Yield 2026 1.18%
Manager TitleAgeSince
Chief Executive Officer 56 08/05/2021
Director of Finance/CFO - 15/02/2017
Compliance Officer - 11/02/2024
Director TitleAgeSince
Director/Board Member 44 21/06/2011
Director/Board Member 75 28/12/2009
Director/Board Member 57 23/10/1994
Change 5-day change 1-year change 3-year change Capi.($)
-0.02%-4.36%+37.11%-4.13% 79.3B
-0.44%+1.45%-18.40%-37.28% 59.21B
+2.47%+1.85%+484.81%+25.11% 55.09B
-6.78%-4.19%-3.45%+28.01% 49.86B
-0.97%-2.55%+7.63%+158.94% 47.9B
-0.35%-0.12%+56.02%-18.52% 32.28B
-1.32%-3.86%+43.10%+90.66% 25.21B
-3.44%+1.37%+7.18%+188.73% 23.87B
-3.17%0.00%+59.72%+113.61% 16.89B
Average -1.58%-1.20%+74.86%+60.57% 43.29B
Weighted average by Cap. -1.20%-2.05%+84.26%+40.99%

Financials

2025 2026
Net sales 4.69B 49.12M 49.12M 42.33M 39.69M 36.23M 68.25M 68.47M 471M 184M 2.37B 184M 180M 7.86B 5.25B 54.98M 54.98M 47.37M 44.42M 40.55M 76.38M 76.63M 527M 206M 2.65B 206M 202M 8.79B
Net income 769M 8.04M 8.04M 6.93M 6.5M 5.93M 11.17M 11.21M 77.09M 30.08M 388M 30.19M 29.54M 1.29B 718M 7.51M 7.51M 6.47M 6.07M 5.54M 10.43M 10.47M 71.98M 28.08M 362M 28.19M 27.58M 1.2B
Net Debt 443M 4.63M 4.63M 3.99M 3.74M 3.42M 6.44M 6.46M 44.41M 17.33M 224M 17.39M 17.01M 741M 806M 8.43M 8.43M 7.26M 6.81M 6.22M 11.71M 11.75M 80.81M 31.53M 407M 31.65M 30.96M 1.35B
Logo Dil Ltd
Fermenta Biotech Limited is an India-based company that is engaged in the manufacturing of vitamin D, active pharmaceutical ingredients (APIs), enzymes and providing environmental solutions services. It is also engaged in renting and selling properties. Its segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. It has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and others. It provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. It also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, and vitamin AD2 premix, among others.
Employees
-